Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
Evan A. Stein, Dan Gipe, Jean Bergeron, Daniel Gaudet, Robert Weiss, Robert Dufour, Richard Wu, Robert C. Pordy
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/s0140-6736(12)60771-5
- Published
- May 25, 2012
- Venue
- The Lancet
- DOI
- 10.1016/s0140-6736(12)60771-5
- PubMed
- 22633824
- Categories
- Lipoproteins and Cardiovascular Health
- Provenance
- openalex